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A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d Scientific knowledge on the subject: Prior research suggests that lung disease and impaired lung function may be linked to dementia, however few studies have been prospective, evaluated different types of lung disease, or considered lung health in midlife.
What this study adds: In a community-based cohort followed for 27 years, both restrictive and, to a lesser extent, obstructive lung disease were associated with greater risk of incident dementia and mild cognitive impairment (MCI). This pattern was present for both Alzheimer's disease-related dementia and cerebrovascular disease etiologies, and persisted in analyses restricted to nonsmokers.
Online Data Supplement:
This article has an online data supplement, which is accessible from this issue's table of content online at www.atsjournals.org
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d and impaired lung function are preventable, and growing evidence suggests that compromised lung health may be linked to greater risk of dementia or worsening cognitive ability. (3, 4) Evidence exists for lung impairment as assessed by objective measures such as low forced expiratory volume in 1 second (FEV 1 ), forced vital capacity (FVC) and the ratio of FEV 1 /FVC, (5) (6) (7) (8) as well as clinically recognized chronic obstructive pulmonary disease (COPD), asthma, or chronic bronchitis.(9-11) Though these prior studies provide valuable information about the possible role of lung health in dementia risk, they often lacked comprehensive event adjudication or had relatively short follow-up. Importantly, for many dementia risk factors, stronger associations have been observed when the risk factors were measured at middle-age than when they were measured later in life. (12) (13) (14) Mechanistically, impaired lung function could influence dementia and MCI risk through several pathways, largely mediated through chronic hypoxemia. (3, 15) These include systemic inflammation, oxidative stress, physiological stress (e.g. sympathetic nervous system activation), and cerebral arterial stiffness and small-vessel damage. (3, 15) Impaired lung function has also been linked to incident stroke, independent of smoking. (16, 17) Hypoxemia within the context of obstructive sleep apnea has also been associated with greater risk of dementia. (18) A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d A m e r i c a n T h o r a c i c
S o c i e t y
Using data from the community-based Atherosclerosis Risk in Communities (ARIC) cohort, we tested the hypotheses that development of dementia and MCI over 27 years of follow-up would be more common among participants who at baseline had a) COPD or restrictive impairment or b) poorer lung function, as assessed by spirometry. Analyses were also conducted according to dementia or MCI primary etiology (i.e. Alzheimer's disease (AD) or cerebrovascular disease). Furthermore, given the importance of smoking to lung health, additional analyses were conducted restricted to nonsmokers. Lastly, we explored interactions by race.
METHODS
The ARIC study is a community-based prospective cohort of 15,792 participants who in 1987- A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d Thoracic Society guidelines(20), as has been described previously in ARIC (21) and is detailed in the Supplemental Methods. Briefly, for each participant, at least three acceptable spirograms were sought from a minimum of five forced expirations, and a best reading was then selected.
FEV1, FVC, and the FEV1/FVC ratio, as a percentage of age-, race-and sex-specific predicted values and lower limit of normal (LLN) values, were calculated. (22) Participants also self-reported whether a doctor has ever told them they had asthma, 4. 'Normal' (without respiratory symptoms, COPD or restrictive impairment)
Covariates and potential effect modifiers
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d A m e r i c a n T h o r a c i c
S o c i e t y
Covariate information was obtained at baseline, using standard ARIC procedures (Supplemental Methods). Briefly, questionnaire data was obtained, height, weight and sitting blood pressure were measured, a fasting blood draw was conducted, and information on participant medication bottles (which were brought to the visit) was recorded. Methods for the measurement and classification of the APOE ɛ4 risk allele have been described elsewhere.(5)
Dementia and MCI ascertainment
Several different approaches were used to ascertain dementia and MCI during follow-up. For analyses of the association between baseline lung function and risk of the neurocognitive study adjudicated outcomes we used logistic regression. Five outcomes were considered: 1) dementia or MCI, 2) dementia, 3) MCI, 4) dementia or MCI due to AD, 5) dementia or MCI due to cerebrovascular disease. For outcomes 2 through 5, we excluded from the analyses those with outcomes different from the outcome under study (e.g. for the dementia outcome, dementia was defined as 'yes' or 'no', and participants with MCI were excluded). For these analyses selection bias may have occurred as a result of differential participation and survival to visit 5. As such, we used inverse probability weighting (IPW) (26, 27) to adjust for attrition due to either death or failure to attend the follow-up neurocognitive Multiplicative interactions by race were explored by including cross-product terms in the models. Additionally, because of the importance of smoking on lung health, we also conducted analyses restricted to nonsmokers. Statistical significance was defined as alpha = 0.05.
RESULTS
At baseline the 14,184 participants included in this analysis were on average 54.2 ± 5.8 years old, 55.3% were female and 25.9% African American. Supplemental Table 1 provides baseline participant characteristics according to whether the participants took part in visit 5, were alive but did not take part, or died prior to visit 5. Those who participated in visit 5 were on average slightly younger, had higher educational attainment, were less likely to smoke, and overall had a slightly better health profile than those who did not take part or died.
At baseline, mean ± standard deviation (SD) measured FEV 1 was 2.82 ± 0.77 L (percent predicted 93.5% ± 17.0), measured FVC 3.80 ± 0.99 L (% predicted 98.1% ± 14.6) and FEV 1 /FVC 74.4 ± 8.1% (% predicted 94.5 ± 10.0%). A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d Table 2 . In analyses restricted to never smokers (N = 6,018, Supplemental Table 3) , results were generally similar to those of the full analyses, though CIs were less precise. In model 3, the HRs for COPD and restrictive impairment, versus being classified as normal, were 1.31 (0.99-1.72) and 1.12 (0.78-1.62), respectively. Although interactions by race were not statistically significant at p=0.05, associations were generally stronger in blacks than in whites (Supplemental Table 4 and FVC% predicted there was some evidence that the proportional hazards assumption was violated, whereby associations were stronger earlier in follow-up than later in follow-up (Supplemental Table 5 ).
Lung disease, lung function and incident dementia

Lung disease, lung function and neurocognitive study-adjudicated dementia
Among the 5,889 participants who had lung function data and cognitive assessments as part of the neurocognitive exam, we also evaluated the association between baseline lung disease category and risk of dementia or MCI, dementia, MCI, and MCI or dementia due to AD, or due to cerebrovascular disease ( Table 6 ). For instance, after model 3
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d There was some evidence of effect modification by race, as shown in Supplemental Table 7 .
Among blacks, the COPD pattern was most associated with elevated odds of the outcomes [e.g. ORs for the associations of FEV 1 % predicted and odds of outcomes are shown in Table 4 .
The lowest (versus highest) quartile of FEV 1 % predicted was associated with an OR of 1.27
(1.05-1.54) for dementia or MCI, after model 3 adjustments. The ORs were 1.23 (0.98-1.54) for dementia or MCI due to AD, and 1.43 (0.91-2.24) for dementia or MCI due to cerebrovascular disease. The associations between FEV 1 % predicted and the dementia outcomes did not differ significantly by race, however in general, the magnitudes of association were larger in blacks than in whites (Supplemental Table 7 ).
Associations between FVC% predicted and dementia are presented in magnitudes of effect tended to be larger in blacks than in whites (Supplemental Table 7 ).
FEV 1 /FVC % predicted was not associated with risk of any of the outcomes, regardless of degree of adjustment (Supplemental Table 8 ).
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d 
DISCUSSION
Lung disease and impaired lung function were associated with greater risk of dementia and MCI in this community-based sample of more than 14,000 individuals followed for over 23 years.
Several important patterns emerged, particularly in analyses employing adjudicated neurocognitive outcomes, though associations were at most of moderate strength and results
were not always statistically significant after multivariable adjustment for a broad array of dementia risk factors. First, though both the COPD and restrictive impairment patterns tended to be associated with greater dementia and MCI risk, the magnitude of association was generally stronger for the restrictive impairment pattern. Second, there was evidence that suboptimal lung health may be related to dementia or MCI risk through both AD and cerebrovascular etiologies. Third, patterns were similar among nonsmokers, as in the overall population. Fourth, when evaluating spirometric measures and dementia risk, inverse associations were present for FEV 1 % predicted and FVC% predicted, but not for the ratio In the present analysis associations between lung disease and function persisted even in analyses restricted to nonsmokers. This enhances etiological understanding -as it suggests that impaired lung function is linked to dementia and MCI risk independent of smoking and smoking-related confounders.
An unexpected finding from the present analysis was the suggestive (but nonsignificant) difference in associations by race, whereby among blacks the COPD pattern was most strongly associated with dementia and MCI risk, whereas in whites the restrictive impairment pattern was most strongly associated. Importantly, both restrictive impairment and COPD are heterogeneous classifications, and the prevalence of specific pathologies is known to vary by A m e r i c a n T h o r a c i c S o c i e t y then the differences observed in the present study are not unexpected. It is possible that these underlying pathologies differ in their association with dementia and MCI risk, which could explain the observed race differences. Other possible explanations for the interaction are poor precision (e.g. there were only 11 blacks with restrictive impairment and MCI), selection bias that is differential by race, or chance. Future studies should aim to replicate these observations.
Strengths and limitations
The Study publication reported that hospital and death diagnostic codes for dementia had a sensitivity of 25% and a specificity of 99%. (25) This may explain why in the present analysis, as in a prior ARIC analysis,(29) associations were stronger when adjudicated outcomes were employed than when hospitalization ICD codes were also used to define dementia. In the present analysis we used IPW to attempt to correct for selection bias resulting from differential outcome ascertainment between participants and nonparticipants of the neurocognitive exam.
S o c i e t y
The true cognitive status of non-attenders is, however, unknown and it is possible that some bias remained. Nonattendess were also more likely to be smokers, have greater pack years, and more respiratory impairment by both spirometry and self-report. Though we attempted to correct for this selection bias through IPW, the fact that participation at visit 5 was differential by smoking and lung function status is noteworthy.
Additional limitations are the single assessment of lung function, lack of biomarkers to verify AD-type dementia, residual confounding and poor precision for some comparisons despite the relatively large sample size. Additionally, bronchodilation was not used when assessing baseline lung function, and total lung capacity was not quantified. Furthermore, also absent are details about symptoms, such as the nature of dyspnea, chronic cough, chronic sputum production or history of recurrent lower respiratory tract infections. Despite these limitations our study had important strengths, including the large community-based sample, objective ascertainment of lung function in using standardized protocols, comprehensive neurocognitive assessment, and representation of men and women and blacks and whites.
CONCLUSIONS
In this large prospective community-based cohort both lung disease and impaired lung function were associated with greater risk of dementia and MCI over 23 years of follow-up, with evidence that this occurred for dementia due to both AD and vascular etiologies. Although both COPD and restrictive impairment were associated with increased risk of the dementia phenotypes, magnitudes of association were most pronounced for restrictive impairment.
These associations were present in both smokers and nonsmokers. If the observed associations A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d 
